Alnylam Pharmaceuticals
ALNY
#567
Rank
NZ$61.58 B
Marketcap
$477.78
Share price
-2.20%
Change (1 day)
70.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company